Narnolia

Narnolia

Toll Free No: 1800-103-7212

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE2637.4051.9 (+2.01 %)
PREV CLOSE ( ) 2585.50
OPEN PRICE ( ) 2614.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2637.40 (16)
VOLUME 66531
TODAY'S LOW / HIGH ( )2558.00 2649.95
52 WK LOW / HIGH ( )1888 2875
NSE2639.5053.2 (+2.06 %)
PREV CLOSE( ) 2586.30
OPEN PRICE ( ) 2584.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2639.50 (1480)
VOLUME 1378159
TODAY'S LOW / HIGH( ) 2555.70 2650.00
52 WK LOW / HIGH ( )1872.95 2878
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
22Feb Dr Reddy's Laboratories recalls 2,770
Dr Reddy's Laboratories is recalling 2,770 bags (277 selling units) of e..
22Feb USFDA completes audit at Dr. Reddy's L
The US Food and Drug Administration (USFDA) has completed audit at Dr. R..
22Feb Dr. Reddys Laboratories trades higher
Dr. Reddys Laboratories is currently trading at Rs. 2628.00, up by 42.50..
21Feb TCS, Zuari Agro Chemicals and Dr Reddy
Tata Consultancy Services (TCS) has partnered with Nanoheal, a predictiv..
21Feb Dr. Reddy's Lab re-launches Buprenorph
Dr. Reddy's Laboratories along with its subsidiaries, has re-launched Bu..
Financials
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit39945669
Gross Profit 5704 6970
Operating Profit 779715339
Net Sales 2731793593
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Pfizer (BSE)
peergroup  2998.60 (2.37%)
M.Cap ( in Cr)13717.91
Piramal Enterprises (BSE)
peergroup  2302.20 (2.77%)
M.Cap ( in Cr)42369.73
Coral Laboratories (BSE)
peergroup  319.60 (6.64%)
M.Cap ( in Cr)114.18
Astrazeneca Pharma I (BSE)
peergroup  1871.00 (0.90%)
M.Cap ( in Cr)4677.50
Divis Lab (BSE)
peergroup  1565.05 (0.98%)
M.Cap ( in Cr)41547.16
Shareholding Pattern
FI/BANKS/INSURANCE 5.54%
PROMOTERS 26.77%
NON-INSTITUTION 13.94%
MUTUAL FUNDS/UTI 10.42%
GOVERNMENT 0%
FII 0%
About Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories Ltd. was incorporated in the year 24-02-1984. Its today's share price is 2637.4. Its current market capitalisation stands at Rs 43796.89 Cr. In the latest quarter, company has reported Gross Sales of Rs. 142810 Cr and Total Income of Rs.144362 Cr. The company's management includes Sandeep Poddar, Bruce L A Carter, Bharat N Doshi, Anupam Puri, GV Prasad, K Satish Reddy, Sridar Iyengar, Prasad R Menon, Omkar Goswami, Kalpana Morparia.

It is listed on the BSE with a BSE Code of 500124 , NSE with an NSE Symbol of DRREDDY and ISIN of INE089A01023. It's Registered office is at 8-2-337, Road No. 3,Banjara Hills,Hyderabad-500034, Telangana. Their Registrars are ACC Ltd. It's auditors are A Rama Chandra Rao & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, SR Batliboi & Associates LLP

Directory

IPO
Narnolia Research & Advisory Narnolia Trading Platforms Narnolia Online | media Room